Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[When to continue or stop Clozapine therapy?].

I Jalenques1, A J Coudert

  • 1Service de Psychiatrie A, CHRU Saint-Jacques, Ferrand.

L'Encephale
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort.

Revue neurologique·2024
Same author

French guidelines for the diagnosis and management of Tourette syndrome.

Revue neurologique·2024
Same author

[Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].

L'Encephale·2016
Same author

High prevalence of psychiatric disorders in patients with skin-restricted lupus: a case-control study.

The British journal of dermatology·2016
Same author

[Health-related quality of life evaluation of elderly aged 65 years and over living at home].

Revue d'epidemiologie et de sante publique·2015
Same author

[Emotional valence of words in schizophrenia].

L'Encephale·2012
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
Same journal

Alternative model for personality disorders and drug use among the homeless individuals.

L'Encephale·2026
See all related articles

Deciding to stop clozapine for schizophrenia involves weighing benefits against risks. Patient status, symptom efficacy (especially positive symptoms), and side effects like leucopenia guide this critical decision.

Area of Science:

  • Pharmacology
  • Psychiatry
  • Clinical Medicine

Context:

  • Clozapine is a crucial antipsychotic for schizophrenia, but treatment decisions require careful benefit-risk assessment.
  • Discontinuation hinges on multiple factors, including clinical status, efficacy, and tolerability.

Purpose:

  • To analyze the multifaceted factors influencing the decision to discontinue clozapine therapy in schizophrenic patients.
  • To evaluate the efficacy of clozapine across different symptom domains and the duration needed for assessment.

Summary:

  • Clozapine's efficacy is most pronounced for positive symptoms of schizophrenia, with variable effects on negative symptoms.
  • Patient-reported outcomes, tolerability, and severe side effects (hematologic, cardiovascular, hepatic, CNS) are key considerations.

Related Experiment Videos

  • Monitoring white blood cell count (WBC) is critical, with specific protocols for counts below 3,500/mm³.

    • Impact:

    • Provides a framework for clinicians to optimize clozapine treatment duration and discontinuation decisions.
    • Highlights the importance of individualized patient assessment, balancing therapeutic benefits with potential adverse events.
    • Informs clinical practice regarding clozapine management, particularly concerning monitoring and side effect handling.